Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

NIH Supporting Electronic Neuro Drug Test Technology

Neurons

A university spin-off enterprise is receiving funds from National Institute of Mental Health to develop a simple, reliable electronic device to evaluate effects of neurological drugs on brain cells. . . . → Read More: NIH Supporting Electronic Neuro Drug Test Technology

Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Handshake

Drug maker AbbVie and biotechnology company Morphic Therapeutic are collaborating on new treatments for fibrosis based on Morphic’s technology blocking proteins that promote fibrosis. . . . → Read More: Harvard Spin-Off, AbbVie Partner on Fibrosis Treatments

Diabetes Drug Assessed Long-Term Against All Other Treatments

Bathroom scale

A new clinical trial is testing the drug semaglutide for people with type 2 diabetes against as many as 40 other diabetes treatments when used as a supplemental drug over 2 years. . . . → Read More: Diabetes Drug Assessed Long-Term Against All Other Treatments

Antibody Designed to Stop Inflammation Protein in Brain

Katerina Akassoglou

A synthetic antibody is shown in tests with lab mice to block the blood protein fibrin from causing inflammation and related damage to brain cells found in neurodegenerative diseases. . . . → Read More: Antibody Designed to Stop Inflammation Protein in Brain

Cancer Antibody Trials Stopped After Patient Death

Stop signs graphic

Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects. . . . → Read More: Cancer Antibody Trials Stopped After Patient Death

Prenatal Genome Edits Prevent Inherited Liver Disorder

Editing DNA

Research with lab mice shows prenatal genome editing with techniques including Crispr can correct an inherited defect associated with a fatal congenital liver disorder. . . . → Read More: Prenatal Genome Edits Prevent Inherited Liver Disorder

Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

T-cells illustration

A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells. . . . → Read More: Start-Up Developing Immunometabolism Therapies, Gains $30M Funding

Trials to Test Stem Cell Treatments for Eye Injuries

Retina close-up

A series of clinical trials are planned to test the use of adult stem cells to treat injuries to the eyes that lead to vision loss. . . . → Read More: Trials to Test Stem Cell Treatments for Eye Injuries

Biotech in $3.7B Licensing Deal for Hepatitis-B

Hepatitis-B virus

A biotechnology company developing therapies that silence the actions of disease-causing genes is licensing its treatment program for hepatitis-B to Janssen Pharmaceuticals. . . . → Read More: Biotech in $3.7B Licensing Deal for Hepatitis-B

Human Antibodies Devised for Snakebite Treatment

Black mamba snake

An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake. . . . → Read More: Human Antibodies Devised for Snakebite Treatment